Hester Biosciences is currently trading at Rs. 1476.00, up by 11.10 points or 0.76% from its previous closing of Rs. 1464.90 on the BSE.
The scrip opened at Rs. 1470.00 and has touched a high and low of Rs. 1477.00 and Rs. 1464.20 respectively. So far 106 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2044.40 on 24-Sep-2019 and a 52 week low of Rs. 1043.25 on 29-Jan-2019.
Last one week high and low of the scrip stood at Rs. 1580.75 and Rs. 1461.75 respectively. The current market cap of the company is Rs. 1256.46 crore.
The promoters holding in the company stood at 53.74%, while Institutions and Non-Institutions held 2.36% and 43.90% respectively.
Hester Biosciences has received an approval for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 150 crore. The Board of Directors in their meeting held on December 18, 2019, approved the same.
Hester Biosciences is engaged in the manufacturing of poultry vaccines.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1480.40 |
Dr. Reddys Lab | 5884.45 |
Cipla | 1481.25 |
Zydus Lifesciences | 1101.45 |
Lupin | 1639.80 |
View more.. |